Brand owners may use a multitude of approaches to crack down effectively on fake drugs. Andy Leck and Ren Jun Lim discuss the challenges of anti-counterfeiting efforts in Singapore.
In May this year, as part of the annual Operation Pangea, an Interpol-led international internet week of action targeting the illegal online sale of counterfeit and unlicensed medicines, the Singapore Health Sciences Authority (HSA) seized more than 56,000 units of counterfeit health products, with a total estimated street value of more than US$320,000. More than 60% of the counterfeit health products seized were sexual enhancement drugs, some of which contained undeclared potent Western medicinal ingredients like tadalafil.
In light of this crackdown, we consider the existing legal framework in Singapore for drug anti-counterfeiting actions and set out the legal and practical challenges involved. To curb such activities effectively, right owners should consider alternative modes of enforcement and wield them in combination for effective brand protection.
Existing legal framework
You need a subscription to continue reading this content.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
News stories up to a week old and feature articles on the day of publication are accessible with a BASIC FREE ACCOUNT.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’; and for basic access to the latest news on the website and weekly email news alerts choose the 'BASIC FREE ACCOUNT' registration.
counterfeits; HSA; trademark infringement; IP enforcement